Nothing Special   »   [go: up one dir, main page]

Stojkovic et al., 2014 - Google Patents

Interleukin‐33 induces urokinase in human endothelial cells―possible impact on angiogenesis

Stojkovic et al., 2014

View HTML @Full View
Document ID
3161914069512310198
Author
Stojkovic S
Kaun C
Heinz M
Krychtiuk K
Rauscher S
Lemberger C
De Martin R
Gröger M
Petzelbauer P
Huk I
Huber K
Wojta J
Demyanets S
Publication year
Publication venue
Journal of thrombosis and haemostasis

External Links

Snippet

Background Urokinase‐type plasminogen activator (u‐PA) plays a pivotal role in extracellular proteolysis and is thought to be critically involved in the modulation of angiogenesis. Interleukin (IL)‐33 is a member of the IL‐1 cytokine family, which is thought to …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones

Similar Documents

Publication Publication Date Title
Stojkovic et al. Interleukin‐33 induces urokinase in human endothelial cells―possible impact on angiogenesis
Davis et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms
Scatena et al. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease
Xie et al. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis
Yamamoto et al. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly
Sukhova et al. Evidence for increased collagenolysis by interstitial collagenases-1 and-3 in vulnerable human atheromatous plaques
Goldman et al. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin
Comerota et al. A histological and functional description of the tissue causing chronic postthrombotic venous obstruction
Suzuki et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells
Brownstein et al. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages
Xu et al. IFN-γ induces gastric cancer cell proliferation and metastasis through upregulation of integrin β3-mediated NF-κB signaling
Johnston et al. Osteopontin as a target for cancer therapy
Miyanishi et al. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles
Krstić et al. Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration
EA020764B1 (en) Biomarkers for inhibitors with anti-angiogenic activity
Tucker et al. Lipoprotein receptor–related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells
Cai et al. Cathepsin L promotes vascular intimal hyperplasia after arterial injury
Stavik et al. EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells
Rabizadeh et al. The cell-membrane prothrombinase, fibrinogen-like protein 2, promotes angiogenesis and tumor development
Joghetaei et al. The Extracellular Matrix Metalloproteinase Inducer (EMMPRIN, CD147)-a potential novel target in atherothrombosis prevention?
Sato et al. Thrombin induced by the extrinsic pathway and PAR-1 regulated inflammation at the site of fracture repair
Zimmermann-Geller et al. Influence of extracellular RNAs, released by rheumatoid arthritis synovial fibroblasts, on their adhesive and invasive properties
Chabot et al. Urokinase-type plasminogen activator receptor interaction with β1 integrin is required for platelet-derived growth factor-AB-induced human mesenchymal stem/stromal cell migration
Giraud et al. Gingival fibroblasts protect against experimental abdominal aortic aneurysm development and rupture through tissue inhibitor of metalloproteinase-1 production
AU2011295030A1 (en) A novel diagnostic and therapeutic target in inflammatory and/or cardiovascular diseases